Home › NDC Lookup › Ingredients › Tolnaftate Powder Spray - Talc Free › 70000-0322-01
💨image loading
(from DailyMed)

Tolnafate Tolnaftate Powder Spray - Talc Free 1.3 g/130g Aerosol, Spray, 130 g — NDC 70000-0322-1 (Billing 70000-0322-01)

by LEADER/ Cardinal Health 110, Inc. · 130 g in 1 CAN

This is a package of 130 g of Tolnafate Tolnaftate Powder Spray - Talc Free 1.3 g/130g Aerosol, Spray from LEADER/ Cardinal Health 110, Inc., marketed since Oct 2017 and currently FDA-listed; retail pharmacies pay about $0.0328 per g (NADAC). It is this product's only package size.

NDC 70000-0322-01
🏷️ FDA NDC (as labeled) 70000-0322-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 70000-0322-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
70000 labeler · 0322 product · 1 package
Package marketed since
Oct 20, 2017
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
130 g per package
Barcode (UPC-A, from the NDC)
3 7000003221 0
Medicaid fills, this package
442 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0322-1
Product NDC 70000-0322
11-digit billing NDC 70000032201
NCPDP billing unit GM — per gram (weight)
RxCUI 705934
UNII 06KB629TKV
Application # M005
SPL Set ID a9fdd129-9909-4747-bd9f-93a204b50724
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2017-10-20
Route TOPICAL
Dosage form AEROSOL, SPRAY
Substance TOLNAFTATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90150085003305
GPI class Athletes Foot Powder Spray
GCN Seq No 007336
GCN 30290
HICL code 003186
Ingredient (HICL) Tolnaftate
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5F
Therapeutic class — specific (HIC3) Topical Antifungals
AHFS code 84:04.08.40
AHFS class Thiocarbamates(Skin And Mucous Membrane)
FDB label name ATHLETE'S FOOT 1% POWDER SPRAY
FDB brand name Athlete's Foot
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 007336
  • GCN: 30290
  • GPI-14 (Medi-Span): 90150085003305
  • HICL (First Databank): 003186
  • AHFS class code: 84:04.08.40
  • RxCUI (RxNorm): 705934
Why two NDCs? The FDA registers this code as 70000-0322-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0322-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antifungals for topical use class.

Drug family (ATC) Other antifungals for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ATHLETE'S FOOT 1% POWDER SPRAY Ingredient Tolnaftate
📗 Our plain-language guide HelloPharmacist
  • It treats fungal skin infections like athlete's foot, ringworm and, in some products, jock itch. Many products also help prevent athlete's foot. Some are made for skin around the n...
  • Wash and dry the area well, then apply a thin layer. Most products are used twice a day, morning and night. The length of use varies, often 4 weeks for athlete's foot and ringworm,...
  • The main one is skin irritation. If that happens, stop using it and talk to a doctor.
  • Call if you see no improvement within 4 weeks for athlete's foot or ringworm, or 2 weeks for jock itch. Call if irritation develops. Call right away if anyone swallows it.
📖 Read our full Tolnaftate guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.033 $4.26 / 130 g
Medicaid paysCMS SDUD · 12 mo $0.0875 $11.38 / 130 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Jul 2023 Jan 2026 May 2026 Sep 2026 $0.033 $0.028
▲ Up 16% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0322-01 You're viewing this Main listing 130 g in 1 CAN 2017-10-20 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Tolnafate 1.3 g/130gthis 70000-0322-01 LEADER/ 130 g $0.033 — Availability likely —
Tolnaftate 1.3 g/113g 00363-0216-13 Walgreen 113 g — — FDA listed —
Tolnaftate 1.3 g/130g 00363-1746-00 Walgreens 130 g — — FDA listed —
Blistex Odor-Eaters Powder 1 g/100g 10157-4645-01 Blistex 113 g — — FDA listed —
Lotrimin Daily Prevention Deo 10 mg/g 11523-0010-01 Bayer 160 g — — FDA listed —
Lotrimin Daily Prevent Deodorant 10 mg/g 11523-0136-01 Bayer 160 g — — FDA listed —
Tinactin Deodorant 10 mg/g 11523-0137-01 Bayer 133 g — — FDA listed —
Tinactin Jock Itch 10 mg/g 11523-0138-01 Bayer 133 g — — FDA listed —
Tinactin 10 mg/g 11523-0139-01 Bayer 133 g — — FDA listed —
Tinactin Antifungal 10 mg/g 11523-4162-01 Bayer 133 g — — FDA listed —
Tolnaftate 1.3 g/130g 11822-0782-04 Rite 130 g — — FDA listed —
Kerasal Athletes Foot powder 1 g/100g 16864-0110-01 Advantice 57 g — — Discontinued —
Tolnafate 1.3 g/130g 21130-0215-00 Better 130 g — — FDA listed —
GoodSense Powder Jock Itch Antifungal 10 mg/g 23667-0806-01 Formulated 130 g — — Discontinued —
Walgreens Maximum Strength Jock Itch Antifungal 10 mg/g 23667-0807-01 Formulated 130 g — — Discontinued —
Meijer Maximum Strength Jock Itch Relief Antifungal 10 mg/g 23667-0809-01 Formulated 130 g — — Discontinued —
Meijer Maximum Strength Anthletes foot Antifungal 10 mg/g 23667-0810-01 Formulated 130 g — — Discontinued —
Signature Athletes Foot Antifungal 10 mg/g 23667-0814-01 Formulated 130 g — — Discontinued —
Walgreens Medicated Antifungal Athletes Foot 10 mg/g 23667-0818-01 Formulated 130 g — — Discontinued —
Tolnaftate 1.3 g/130g 30142-0841-01 Kroger 130 g — — FDA listed —
Tolnaftate 1.13 g/113g 36800-0023-04 Topco 113 g — — FDA listed —
Tolnafate 1.3 g/130g 36800-0876-46 Topco 130 g — — FDA listed —
Tolnaftate 1.3 g/130g 36800-0877-46 Topco 130 g — — FDA listed —
Tolnaftate 1.13 g/113g 37808-0514-40 HEB 113 g — — FDA listed —
Tolnafate 1.3 g/130g 37808-0530-46 HEB 130 g — — FDA listed —
Tolnaftate 1.3 g/130g 41250-0563-46 Meijer 130 g — — Discontinued —
Tolnaftate 1.13 g/113g 41520-0086-04 Foodhold 113 g — — FDA listed —
Derman Antifungal 10 mg/g 54312-0230-01 Compania 130 g — — FDA listed —
Antifungal Powder 10 mg/g 55301-0874-01 ARMY 130 g — — FDA listed —
Fungi Nail Everyday Antifungal Powder 1.3 g/130g 55505-0234-81 Kramer 130 g — — FDA listed —
Hongo Killer .1 g/10g 58593-0285-04 Efficient 130 g — — FDA listed —
Tolnafate 1.3 g/130g 63868-0181-46 Chain 130 g — — FDA listed —
Tolnafate 1.3 g/130g 63941-0540-46 VALU 130 g — — FDA listed —
Tolnafate 1.3 g/130g 63941-0541-46 VALU 130 g — — FDA listed —
Tolnafate 1.3 g/130g 68016-0653-46 Chain 130 g — — FDA listed —
Tolnafate 1.3 g/130g 68016-0663-46 Chain 130 g — — FDA listed —
Tolnafate 1.3 g/130g 69842-0512-46 CVS 130 g — — FDA listed —
Tolnafate 10 mg/g 79481-0607-01 Meijer 130 g — — FDA listed —
Foot Odor Control Powder 10 mg/g 79481-0622-01 Meijer 113 g — — FDA listed —
Tolnafate 10 mg/g 79481-0623-01 Meijer 130 g — — FDA listed —
Tolnafate 1.3 g/130g 79903-0016-46 Wal-Mart 130 g — — FDA listed —
Derman Antifungal Powder Tolnaftate 10 mg/g 81929-0001-01 Taisho 1 can — — FDA listed —
Tolnaftate 10 mg/g 82442-0402-01 Target 113 g — — FDA listed —
Tolnafate 10 mg/g 83324-0234-46 Chain 130 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2017
On the market since
Oct 2017
📍
2026
Currently FDA-listed
9 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerLEADER/ Cardinal Health 110, Inc.
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedOct 2017
Product typeHuman Otc Drug
Portfolio38 products on file

More NDCs from LEADER/ Cardinal Health 110, Inc. labeler code 70000

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 37 words ▾

Uses cures most athlete’s foot (tinea pedis), ringworm (tinea corporis), and jock itch (tinea cruris) can prevent recurrence of most athlete’s foot relieves symptoms of athlete’s foot, including itching, burning, cracking, and chafing associated with jock itch

⏱️ Dosage and Administration 102 words ▾

Directions wash affected area and dry thoroughly shake can well and spray a thin layer over affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product for athlete's foot, pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily use daily for 4 weeks for athlete’s foot and ringworm; use daily for 2 weeks for jock itch if condition persists, consult a doctor this product is not effective on the scalp or nails if nozzle clogs, clean with a pin

⚠️ Warnings 116 words ▾

For external use only. Flammable: Do not use while smoking or near heat or flame. Do not puncture or incinerate.

Contents under pressure. Do not store at temperature above 120ºF. Intentional misuse by deliberately concentrating and inhaling contents can be harmful or fatal.

When using this product avoid contact with the eyes or mouth use only as directed Stop use and ask a doctor if no improvement within 4 weeks for athlete’s foot and ringworm; 2 weeks for jock itch irritation occurs Do not use on children under 2 years of age unless directed by a doctor. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 4 words ▾

Active ingredient Tolnaftate 1%

🧪 Inactive Ingredients 13 words ▾

Inactive ingredients BHT, isobutane, kaolin, PPG-12-buteth-16, SD alcohol 40-B, zea mays (corn) starch

🎯 Purpose 2 words ▾

Purpose Antifungal

📄 Do Not Use 15 words ▾

Do not use on children under 2 years of age unless directed by a doctor.

📄 When Using This Product 15 words ▾

When using this product avoid contact with the eyes or mouth use only as directed

📄 Stop Use and Ask a Doctor If 24 words ▾

Stop use and ask a doctor if no improvement within 4 weeks for athlete’s foot and ringworm; 2 weeks for jock itch irritation occurs

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 10 words ▾

Other information store between 20º and 30ºC (68ºF and 86º)

📄 Questions or Comments 3 words ▾

Questions? Call 1-866-964-0939

📄 Package Label / Principal Display Panel 37 words ▾

Principal Display Panel LEADER Antifungal Athlete's Foot Powder Spray Tolnaftate 1 % | Antifungal Cure Most Athlete's Foot and Prevents Recurrences Relieves Itching, Cracking, and Burning Talc- Free

4.6OZ (130 g) Leader_Antifungal Tolnaftate Powder Spray Talc-Free_50-060LD.jpg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
442
Units reimbursed last 4 qtrs
57.4K
Gross reimbursed last 4 qtrs
$5K
Avg / prescription
$11.37
Avg / unit
$0.0875
Latest quarter Q1 2026
94Rx
Medicaid pays / g
$0.0875
gross reimbursed
vs
NADAC / g
$0.0328
acquisition cost
=
Spread
+$0.0547
+167% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
45% FFS 55% MCO
Fee-for-service · 198 Rx Managed care · 244 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 1,936 units · 33.7 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 31,850 units · 270 per 100k residents OH Pennsylvania: 11,443 units · 88.3 per 100k residents PA New Jersey: 7,150 units · 77.0 per 100k residents NJ Massachusetts: no data reported MA California: 1,560 units · 4.0 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 2,049 units · 45.3 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 1,430 units · 4.7 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.0270
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Ohio 270 /100k
2 Pennsylvania 88.3 /100k
3 New Jersey 77.0 /100k
4 Kentucky 45.3 /100k
5 Minnesota 33.7 /100k
6 Texas 4.7 /100k
7 California 4.0 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 70000-0321-01 · Cardinal 70000-0323-01 · LEADER/ →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.